# OnCo record attraction-2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/attraction-2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "attraction-2", "NCT02267343" ;
  schema:name "ATTRACTION-2"@en ;
  schema:description "ATTRACTION-2 was the first randomised trial to show that an immunotherapy drug, nivolumab, helps people with heavily pretreated stomach cancer live longer than placebo, and it made nivolumab a late-line option in East Asia before any Western approval."@en ;
  schema:url <https://onco.cc/trials/attraction-2/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02267343> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/gastric-pdl1-high/>, <https://onco.cc/cancers/gastric/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:people <https://onco.cc/people/kang-yoon-koo/> .